COMMUNIQUÉS West-GlobeNewswire
-
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
18/03/2024 - 13:55 -
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
18/03/2024 - 08:00 -
OBI Pharma Announces Poster Presentations at the AACR 2024 Annual Meeting for OBI-992 and GlycOBI™ ADC platform
18/03/2024 - 10:00 -
Completion of share buy-back program
18/03/2024 - 10:49 -
Idorsia and Viatris successfully close the transaction for the global research and development collaboration
18/03/2024 - 07:00 -
Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMed
18/03/2024 - 07:00 -
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
18/03/2024 - 07:00 -
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
18/03/2024 - 07:30 -
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
18/03/2024 - 02:00 -
Financière de Tubize - Rapport annuel 2023
16/03/2024 - 08:00 -
Financière de Tubize - Annual report 2023
16/03/2024 - 08:00 -
Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics
16/03/2024 - 00:03 -
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
16/03/2024 - 01:01 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2024
15/03/2024 - 20:04 -
Sanofi: Information concerning the total number of voting rights and shares - February 2024
15/03/2024 - 20:04 -
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
15/03/2024 - 20:34 -
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
15/03/2024 - 21:05 -
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
15/03/2024 - 21:05 -
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
15/03/2024 - 21:30
Pages